SanBio Company Limited
Status: Publicly traded
Direct answer
SanBio Company Limited is publicly traded on JPX under the ticker 4592.T.
SanBio Company Limited is dedicated to the creation, production, and sale of regenerative cell therapies, primarily concentrated on disorders of the central nervous system. A central component of their portfolio is SB623, a treatment that has completed Phase 2 clinical trials in both the United States and Japan for traumatic brain injury. Beyond this, their comprehensive research pipeline explores the broader...
Can you invest in SanBio Company Limited?
Yes. SanBio Company Limited trades publicly on JPX as 4592.T.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for SanBio Company Limited
Detailed equity research is provided by MarketSnap.